Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 851

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 851
---
 $ | 1,958,663 |     | $ | 478,890 |

Note 14-Commitmentsand contingencies

Lease Commitments- The Company leases facilities under non-cancelableoperating leases for the laboratory and offices in Tampa, Florida. The current lease expires in February 2026.

Future minimum lease payments under these leases are as follows:

| Year ending December 31, 2025              |     | $ | 172,931 |   |
| Year ending December 31, 2026              |     |   |  43,411 |   |
| Interest portion of right of use liability |     |   | (13,800 | ) |
| Operating lease liabilities                |     | $ | 202,542 |   |

Total lease expense was approximately $ 163,000and $ 126,000for the years ended December 31, 2024 and 2023, respectively.

Cash paid for amounts included in the measurement of lease liabilities was approximately $ 160,000and $ 126,000for the years ended December 31, 2024 and 2023.

For the current lease, the weighted-average lease term is 1.25years and 2.25years and the weighted average discount rate is 10.0% as of December 31, 2024 and 2023

Employment Agreements- In March 2024, the Company signed a consulting agreement with an entity owned by the former CEO and President and paid approximately $ 243,000and $ 555,000for the years ended December 31, 2024 and 2023. In May 2023, and amended in March 2024, and in November of 2024, the Company signed employment agreements with the CEO and CFO.

Future minimum payments under these employment and consulting agreements are as follows:

| Year ending December 31, 2025 |     |          $ | 949,000 |
| Year ending December 31, 2026 |     |            | 874,000 |
|                               |     | $1,823,000 |         |

Note 15-Subsequentevents Subsequent events -The Company has evaluated subsequent events through March 31, 2025 in connection with the preparation of these financial statements, which is the date the financial statements were available to be issued. F-91

TUHURA BIOSCIENCES, INC AND SUBSIDIARIES Notes to the consolidated financial statements For